Together, these results illustrate how different ALS mutations converge on factors controlling axonal RNP motility and dynamic interaction with membrane-bound organelles, highlighting the likely involvement of this process in disease pathogenesis or progression. The gene discussed is RNPC3; the disease is amyotrophic lateral sclerosis.